Common Contracts

SECOND AMENDMENT AND EXTENSION OF STANDSTILL AND FORBEARANCE AGREEMENT

Standstill and Forbearance Agreement • February 2nd, 2021 • GT Biopharma, Inc. • Pharmaceutical preparations

• Contract Type
  Standstill and Forbearance Agreement
• Filed
  February 2nd, 2021
• Company
  GT Biopharma, Inc.
• Industry
  Pharmaceutical preparations

This Second Amendment and Extension of Standstill and Forbearance Agreement (this “Agreement”) is entered into as of January 31, 2021, by and between GT Biopharma, Inc., a Delaware corporation (the “Company”), and [●] (the “Lender”), with respect to that certain Standstill and Forbearance Agreement, dated as of June 23, 2020, between the Company and the Lender (as amended, supplemented, or otherwise modified from time to time, the “Forbearance Agreement”). Any capitalized term used in this Agreement and not otherwise defined shall have the meaning ascribed to it in the Forbearance Agreement.

FIRST AMENDMENT AND EXTENSION OF STANDSTILL AND FORBEARANCE AGREEMENT

Standstill and Forbearance Agreement • November 4th, 2020 • GT Biopharma, Inc. • Pharmaceutical preparations

• Contract Type
  Standstill and Forbearance Agreement
• Filed
  November 4th, 2020
• Company
  GT Biopharma, Inc.
• Industry
  Pharmaceutical preparations

This First Amendment and Extension of Standstill and Forbearance Agreement (this “Agreement”) is entered into as of October 31, 2020, by and between GT Biopharma, Inc., a Delaware corporation (the “Company”), and [●], a [●] (the “Lender”), with respect to that certain Standstill and Forbearance Agreement, dated as of June 23, 2020, between the Company and the Lender (the “Forbearance Agreement”). Any capitalized term used in this Agreement and not otherwise defined shall have the meaning ascribed to it in the Forbearance Agreement.